|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication December 28, 2005.
Revised March 21, 2006.
Accepted for publication March 28, 2006.
Although the level of serum amyloid A has been reported to be up-regulated during inflammatory response, the role of serum amyloid A on the regulation of inflammation and immune response has not been elucidated. We found that serum amyloid A stimulated the production of tumor necrosis factor-
(TNF-
) and IL-10, which are, proinflammatory and anti-inflammatory cytokines, respectively in human monocytes. Low concentrations of serum amyloid A stimulated TNF-
production with maximal activity at 6 hr after stimulation, whereas high concentrations of serum amyloid A stimulated IL-10 production with maximal activity at 12 hr. The activations of the two cytokines by serum amyloid A occurred at both the transcription and translational levels. Signaling events induced by serum amyloid A included the activation of two mitogen activated protein kinase (extracellular signal-regulated kinase and p38 kinase), which were found to be required for TNF-
and IL-10 production, respectively. The stimulation of formyl peptide receptor like 1-expressing RBL-2H3 cells, but not of vector-expressing RBL-2H3 cells with serum amyloid A, induced mitogen activated protein kinases activation and the accumulation of the RNAs of these two cytokines. Taken together, our findings suggest that serum amyloid A modulates contrary immune responses via formyl peptide receptor like 1, by inducing TNF-
or IL-10, and demonstrate that extracellular signal-regulated kinase and p38 kinase play counteracting roles in this process.
Key words:
Interleukins, Gi family, Calcium (G Protein Coupled Signals), MAP Kinase, P38 MAP Kinase
This article has been cited by other articles:
![]() |
H. Y. Lee, S. D. Kim, J. W. Shim, S. Y. Lee, H. Lee, K.-H. Cho, J. Yun, and Y.-S. Bae Serum Amyloid A Induces CCL2 Production via Formyl Peptide Receptor-Like 1-Mediated Signaling in Human Monocytes J. Immunol., September 15, 2008; 181(6): 4332 - 4339. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Hickey, C. F. Brereton, and K. H. G. Mills Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells J. Leukoc. Biol., July 1, 2008; 84(1): 234 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sandri, D. Rodriguez, E. Gomes, H. P. Monteiro, M. Russo, and A. Campa Is serum amyloid A an endogenous TLR4 agonist? J. Leukoc. Biol., May 1, 2008; 83(5): 1174 - 1180. [Abstract] [Full Text] [PDF] |
||||